Our live Investing Matters Podcast Special which took place at the Master Investor Show discussing 'How undervalued is the UK stock market?', has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
pump pump
Or it's consolidating ready to move up to the next resistance level.
Anyone know where that is?
here comes the spike...careful a lot of people will now be selling into this
Great news , this was supposed to be 5pence last week. Or have they forgotten
The 70% rrr referred to in my last post is with reference to todays RNS. Apologies for typo- this appears to refer to antivirals.
In considering the potential of SNG001 we need to look at the competition and how it came to be in common usage. We have relatively little info on out of hospital efficacy at present so we must confine ourselves to looking at in hospital therapies. I have posted here before on this issue.
1) dexamethasone. It took multiple trials over many thousands of patients and a meta-analysis to show efficacy in a subgroup. The main benefit is for those in critical care. At best 30% rrr (relative risk reduction for death).
2) IL6 antagonists. Again mixed results and subgroup analysis needed to show efficacy- again circa 30% rrr in those with CRPs> 175 ( crp is a marker of inflammation).
3) mabs - only work early in disease.
4) antivirals- don’t work in hospital- only efficacy is within 5 days of infection. 70% rrr
This is a strong result today in a population in whom the options are limited. I think we have as good a chance of EUA as many that are in routine use.
I’m holding having topped up in the dip.
dumbpunter is one of life's losers. He bought in here after p2 and then panicked in the vaccine crash and sold at a huge loss and has never got over it. He was even on here at 7am this morning, lol!
#sadact
HSD: “Stop talking about takeovers.
Do you really think anyone's going to pay over £200m for a company that's currently worth £70m?”
Yes.
Dumbpunter is here!
That's a very positive signal, even if his posts are so negative.
Stop talking about takeovers.
Do you really think anyone's going to pay over £200m for a company that's currently worth £70m? Because unless Polygon (who's averaging around £1/share) sells at a loss, that's what it would take.
Yeah man, Im in agreement there. We were getting beaten up real good weren't we.
"Is 20% uplift enough to represent that or should it be more?"
Currently up about 35% which is a bit more like it. I do think this is quite an important RNS though, we were flat on our backs on the canvas and are now upright and landing some shots. One of Takeover, trial partnership or platform trial looks odds on and there is more evidence o the drug being very effective in particualr groups and therefore a a higher chance that any new trial will bear fruit.
Yeah, EUA is many many many bags. Many of them!
MUCH more than 2-3 IMO.
But thats not coming today.
I think this news is worth one bag, but I'm no expert.
Competing in USA against Remdesivir which is backed by Fauci and in U.K. against the antivirals already stockpiled!
https://www.bmj.com/content/375/bmj.n2602
Yeah, a fair observation.
Also, I bought some more as the risk profile changed so guaranteed to try to spike me :)
But as I say, the risk profile has changed significantly today, is 20% uplift enough to represent that or should it be more?
Anywhere in the world!! thats the key thing to remember from the RNS, do not get spiked!!